Published in J Biol Chem on June 15, 2010
miR-214 targets ATF4 to inhibit bone formation. Nat Med (2012) 3.01
The viral and cellular microRNA targetome in lymphoblastoid cell lines. PLoS Pathog (2012) 2.45
The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury. Physiol Genomics (2012) 2.08
MicroRNA control of bone formation and homeostasis. Nat Rev Endocrinol (2012) 2.05
Inflammatory bone loss: pathogenesis and therapeutic intervention. Nat Rev Drug Discov (2012) 1.91
Circulating microRNAs in patients with active pulmonary tuberculosis. J Clin Microbiol (2011) 1.70
MSC Transplantation Improves Osteopenia via Epigenetic Regulation of Notch Signaling in Lupus. Cell Metab (2015) 1.49
miR-218 directs a Wnt signaling circuit to promote differentiation of osteoblasts and osteomimicry of metastatic cancer cells. J Biol Chem (2012) 1.39
Integrated microRNA-mRNA-analysis of human monocyte derived macrophages upon Mycobacterium avium subsp. hominissuis infection. PLoS One (2011) 1.35
miR-29 targets Akt3 to reduce proliferation and facilitate differentiation of myoblasts in skeletal muscle development. Cell Death Dis (2013) 1.26
Downregulation of GAS5 promotes bladder cancer cell proliferation, partly by regulating CDK6. PLoS One (2013) 1.19
TGF-β/BMP signaling and other molecular events: regulation of osteoblastogenesis and bone formation. Bone Res (2015) 1.12
miR-375 regulates rat alveolar epithelial cell trans-differentiation by inhibiting Wnt/β-catenin pathway. Nucleic Acids Res (2013) 1.11
MicroRNA biogenesis and regulation of bone remodeling. Arthritis Res Ther (2011) 1.11
miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma. Neuro Oncol (2010) 1.10
Involvement of miR-30c and miR-301a in immediate induction of plasminogen activator inhibitor-1 by placental growth factor in human pulmonary endothelial cells. Biochem J (2011) 1.09
Control of mesenchymal lineage progression by microRNAs targeting skeletal gene regulators Trps1 and Runx2. J Biol Chem (2012) 1.09
miR-29s: a family of epi-miRNAs with therapeutic implications in hematologic malignancies. Oncotarget (2015) 1.08
MiR-133a in human circulating monocytes: a potential biomarker associated with postmenopausal osteoporosis. PLoS One (2012) 1.06
MiR-27a targets sFRP1 in hFOB cells to regulate proliferation, apoptosis and differentiation. PLoS One (2014) 1.04
MicroRNA in cardiovascular calcification: focus on targets and extracellular vesicle delivery mechanisms. Circ Res (2013) 1.02
miR-30e reciprocally regulates the differentiation of adipocytes and osteoblasts by directly targeting low-density lipoprotein receptor-related protein 6. Cell Death Dis (2013) 1.01
Bone marrow mesenchymal stem cells for post-myocardial infarction cardiac repair: microRNAs as novel regulators. J Cell Mol Med (2012) 0.99
Molecular mechanisms of mesenchymal stem cell differentiation towards osteoblasts. World J Stem Cells (2013) 0.98
miR-214 promotes osteoclastogenesis by targeting Pten/PI3k/Akt pathway. RNA Biol (2015) 0.97
MicroRNA-322 (miR-322) and its target protein Tob2 modulate Osterix (Osx) mRNA stability. J Biol Chem (2013) 0.96
MicroRNAs as novel regulators of stem cell fate. World J Stem Cells (2013) 0.94
miR-29 promotes murine osteoclastogenesis by regulating osteoclast commitment and migration. J Biol Chem (2013) 0.92
Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells. Biomed Res Int (2015) 0.92
Roles of microRNA-29a in the antifibrotic effect of farnesoid X receptor in hepatic stellate cells. Mol Pharmacol (2011) 0.92
MicroRNA-29a promotes colorectal cancer metastasis by regulating matrix metalloproteinase 2 and E-cadherin via KLF4. Br J Cancer (2013) 0.92
MicroRNAs involved in bone formation. Cell Mol Life Sci (2014) 0.92
miR-142-5p and miR-130a-3p are regulated by IL-4 and IL-13 and control profibrogenic macrophage program. Nat Commun (2015) 0.91
Deregulation and therapeutic potential of microRNAs in arthritic diseases. Nat Rev Rheumatol (2015) 0.91
MicroRNAs regulate bone metabolism. J Bone Miner Metab (2013) 0.91
MicroRNAs as regulators of bone homeostasis and bone metastasis. Bonekey Rep (2014) 0.90
miR-346 regulates osteogenic differentiation of human bone marrow-derived mesenchymal stem cells by targeting the Wnt/β-catenin pathway. PLoS One (2013) 0.90
miR-125b Is an adhesion-regulated microRNA that protects mesenchymal stem cells from anoikis. Stem Cells (2012) 0.90
microRNA-29 negatively regulates EMT regulator N-myc interactor in breast cancer. Mol Cancer (2014) 0.90
MicroRNA-29 induces cellular senescence in aging muscle through multiple signaling pathways. Aging (Albany NY) (2014) 0.89
MiR-198 represses tumor growth and metastasis in colorectal cancer by targeting fucosyl transferase 8. Sci Rep (2014) 0.88
MiR-422a as a potential cellular microRNA biomarker for postmenopausal osteoporosis. PLoS One (2014) 0.87
MicroRNA regulation of T-lymphocyte immunity: modulation of molecular networks responsible for T-cell activation, differentiation, and development. Crit Rev Immunol (2013) 0.87
Modulators of the microRNA biogenesis pathway via arrayed lentiviral enabled RNAi screening for drug and biomarker discovery. Comb Chem High Throughput Screen (2013) 0.86
Decreased expression of long non-coding RNA GAS5 indicates a poor prognosis and promotes cell proliferation and invasion in hepatocellular carcinoma by regulating vimentin. Mol Med Rep (2015) 0.86
Canonical wnt signaling regulates extracellular matrix expression in the trabecular meshwork. Invest Ophthalmol Vis Sci (2014) 0.85
IGF-I 3' untranslated region: strain-specific polymorphisms and motifs regulating IGF-I in osteoblasts. Endocrinology (2012) 0.84
microRNA regulation of Wnt signaling pathways in development and disease. Cell Signal (2015) 0.84
MiR-29a modulates the angiogenic properties of human endothelial cells. Biochem Biophys Res Commun (2013) 0.84
MicroRNA Regulation of Human Breast Cancer Stem Cells. J Clin Med (2015) 0.84
MicroRNAs regulate bone development and regeneration. Int J Mol Sci (2015) 0.84
miRNA Control of Tissue Repair and Regeneration. Am J Pathol (2015) 0.83
Next-generation sequencing identifies equine cartilage and subchondral bone miRNAs and suggests their involvement in osteochondrosis physiopathology. BMC Genomics (2014) 0.83
Do epigenetic marks govern bone mass and homeostasis? Curr Genomics (2012) 0.83
Vitamin D and microRNAs in bone. Crit Rev Eukaryot Gene Expr (2013) 0.83
MicroRNAs Regulate Vascular Medial Calcification. Cells (2014) 0.83
TNF-α-induced NF-κB activation upregulates microRNA-150-3p and inhibits osteogenesis of mesenchymal stem cells by targeting β-catenin. Open Biol (2016) 0.82
Pathogenesis of glucocorticoid-induced avascular necrosis: A microarray analysis of gene expression in vitro. Int J Mol Med (2015) 0.82
A single nucleotide polymorphism in osteonectin 3' untranslated region regulates bone volume and is targeted by miR-433. J Bone Miner Res (2015) 0.81
The two faces of miR-29. J Cardiovasc Med (Hagerstown) (2015) 0.81
Post-transcriptional regulation in osteoblasts using localized delivery of miR-29a inhibitor from nanofibers to enhance extracellular matrix deposition. Acta Biomater (2014) 0.81
miR-29a modulates neuronal differentiation through targeting REST in mesenchymal stem cells. PLoS One (2014) 0.81
Mini but mighty: microRNAs in the pathobiology of periodontal disease. Periodontol 2000 (2015) 0.80
Global miRNA expression and correlation with mRNA levels in primary human bone cells. RNA (2015) 0.80
Local activation of cardiac stem cells for post-myocardial infarction cardiac repair. J Cell Mol Med (2012) 0.79
The microRNA-29 family in cartilage homeostasis and osteoarthritis. J Mol Med (Berl) (2015) 0.78
Epigenetic Mechanisms in Bone Biology and Osteoporosis: Can They Drive Therapeutic Choices? Int J Mol Sci (2016) 0.78
Osteogenic, stem cell and molecular characterisation of the human induced membrane from extremity bone defects. Bone Joint Res (2016) 0.78
Wnt/β-catenin pathway transactivates microRNA-150 that promotes EMT of colorectal cancer cells by suppressing CREB signaling. Oncotarget (2016) 0.77
Dynamics and evolution of β-catenin-dependent Wnt signaling revealed through massively parallel clonogenic screening. Integr Biol (Camb) (2014) 0.77
Chromobox Homolog 4 is Positively Correlated to Tumor Growth, Survival and Activation of HIF-1α Signaling in Human Osteosarcoma under Normoxic Condition. J Cancer (2016) 0.77
Mediators of inflammation and bone remodeling in rheumatic disease. Semin Cell Dev Biol (2015) 0.76
TAK-242, a Toll-Like Receptor 4 Antagonist, Protects against Aldosterone-Induced Cardiac and Renal Injury. PLoS One (2015) 0.76
Protective effects of miR-29a on diabetic glomerular dysfunction by modulation of DKK1/Wnt/β-catenin signaling. Sci Rep (2016) 0.76
MiR-26a Rescues Bone Regeneration Deficiency of Mesenchymal Stem Cells Derived From Osteoporotic Mice. Mol Ther (2015) 0.76
Downregulation of MicroRNA-152 contributes to high expression of DKK1 in multiple myeloma. RNA Biol (2015) 0.75
miRNAs in Bone Development. Curr Genomics (2015) 0.75
Interleukin-32 Gamma Stimulates Bone Formation by Increasing miR-29a in Osteoblastic Cells and Prevents the Development of Osteoporosis. Sci Rep (2017) 0.75
MicroRNAs and Bone Regeneration. Curr Genomics (2015) 0.75
Activation of the Wnt Pathway by Mycobacterium tuberculosis: A Wnt-Wnt Situation. Front Immunol (2017) 0.75
The Role of miRNAs in Cartilage Homeostasis. Curr Genomics (2015) 0.75
Bone marrow stroma-derived miRNAs as regulators, biomarkers and therapeutic targets of bone metastasis. Bonekey Rep (2015) 0.75
Stearoyl-CoA Desaturase Promotes Liver Fibrosis and Tumor Development in Mice via a Wnt Positive-Signaling Loop by Stabilization of Low-Density Lipoprotein-Receptor-Related Proteins 5 and 6. Gastroenterology (2017) 0.75
miR-1827 inhibits osteogenic differentiation by targeting IGF1 in MSMSCs. Sci Rep (2017) 0.75
Evidence for Altered Canonical Wnt Signaling in the Trabecular Bone of Elderly Postmenopausal Women with Fragility Femoral Fracture. Biomed Res Int (2016) 0.75
Galectin-3 Inhibition Is Associated with Neuropathic Pain Attenuation after Peripheral Nerve Injury. PLoS One (2016) 0.75
Dicer ablation in osteoblasts by Runx2 driven cre-loxP recombination affects bone integrity, but not glucocorticoid-induced suppression of bone formation. Sci Rep (2016) 0.75
Preliminary evaluation of circulating microRNAs as potential biomarkers in paracoccidioidomycosis. Biomed Rep (2017) 0.75
The Wnt Blows: On the Functional Role of Wnt Signaling in Mycobacterium tuberculosis Infection and Beyond. Front Immunol (2016) 0.75
MicroRNAs in bone diseases. Osteoporos Int (2016) 0.75
Mir-29b Mediates the Neural Tube versus Neural Crest Fate Decision during Embryonic Stem Cell Neural Differentiation. Stem Cell Reports (2017) 0.75
MicroRNAs and Periodontal Homeostasis. J Dent Res (2017) 0.75
Role of the microRNA-29 family in fibrotic skin diseases. Biomed Rep (2017) 0.75
MicroRNA expression profiles classify human cancers. Nature (2005) 69.12
A mammalian microRNA expression atlas based on small RNA library sequencing. Cell (2007) 34.03
c-Myc-regulated microRNAs modulate E2F1 expression. Nature (2005) 31.81
Wnt/beta-catenin signaling in development and disease. Cell (2006) 30.09
MicroRNA maturation: stepwise processing and subcellular localization. EMBO J (2002) 19.47
Fast and effective prediction of microRNA/target duplexes. RNA (2004) 18.10
Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature (2005) 17.17
The microRNA.org resource: targets and expression. Nucleic Acids Res (2007) 16.26
Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA (2004) 11.52
Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet (2007) 10.78
Control of developmental timing by micrornas and their targets. Annu Rev Cell Dev Biol (2002) 7.91
Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views. Stem Cells (2007) 7.57
Wnt signaling in oncogenesis and embryogenesis--a look outside the nucleus. Science (2000) 7.25
RNA polymerase III transcribes human microRNAs. Nat Struct Mol Biol (2006) 6.81
Regulation of bone mass by Wnt signaling. J Clin Invest (2006) 5.59
Gene splicing by overlap extension. Methods Enzymol (1993) 4.59
NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer Cell (2008) 4.57
Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol Cell Biol (1995) 4.28
MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. Proc Natl Acad Sci U S A (2008) 4.06
Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation. J Biol Chem (2009) 3.62
Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass. J Bone Miner Res (2006) 3.44
Beta-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation. Nat Struct Mol Biol (2005) 3.41
BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J Bone Miner Res (2003) 3.32
MAPPER: a search engine for the computational identification of putative transcription factor binding sites in multiple genomes. BMC Bioinformatics (2005) 3.23
Trans-splicing and polyadenylation of let-7 microRNA primary transcripts. RNA (2004) 3.18
MicroRNA-204 regulates Runx2 protein expression and mesenchymal progenitor cell differentiation. Stem Cells (2010) 3.16
A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans. J Clin Invest (2009) 3.03
Characterization of a highly variable eutherian microRNA gene. RNA (2005) 2.72
Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells. J Cell Biochem (2004) 2.71
Osteogenic differentiation of human adipose tissue-derived stem cells is modulated by the miR-26a targeting of the SMAD1 transcription factor. J Bone Miner Res (2008) 2.66
The Yin-Yang of TCF/beta-catenin signaling. Adv Cancer Res (2000) 2.62
Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes. Trends Pharmacol Sci (2003) 2.54
Expression profiling and functional analysis of wnt signaling mechanisms in mesenchymal stem cells. Stem Cells (2004) 2.09
Development and characterization of a conditionally immortalized human fetal osteoblastic cell line. J Bone Miner Res (1995) 1.97
Runx2: a master organizer of gene transcription in developing and maturing osteoblasts. Birth Defects Res C Embryo Today (2005) 1.84
Expression profile of osteoblast lineage at defined stages of differentiation. J Biol Chem (2005) 1.83
miR-29 suppression of osteonectin in osteoblasts: regulation during differentiation and by canonical Wnt signaling. J Cell Biochem (2009) 1.83
MicroRNAs in skeletal and cardiac muscle development. DNA Cell Biol (2007) 1.81
A microRNA regulatory mechanism of osteoblast differentiation. Proc Natl Acad Sci U S A (2009) 1.80
Characterization of function and regulation of miR-24-1 and miR-31. Biochem Biophys Res Commun (2009) 1.60
Suspended cells from trabecular bone by collagenase digestion become virtually identical to mesenchymal stem cells obtained from marrow aspirates. Blood (2004) 1.60
MicroRNA-141 and -200a are involved in bone morphogenetic protein-2-induced mouse pre-osteoblast differentiation by targeting distal-less homeobox 5. J Biol Chem (2009) 1.59
Architecture of a microRNA-controlled gene regulatory network that diversifies neuronal cell fates. Cold Spring Harb Symp Quant Biol (2006) 1.56
Wnt signaling inhibits osteogenic differentiation of human mesenchymal stem cells. Bone (2004) 1.54
Effects of Wnt signaling on proliferation and differentiation of human mesenchymal stem cells. Tissue Eng (2004) 1.51
Wnt signaling in bone metabolism. J Bone Miner Metab (2009) 1.48
miR-210 promotes osteoblastic differentiation through inhibition of AcvR1b. FEBS Lett (2009) 1.46
Functional profiling reveals critical role for miRNA in differentiation of human mesenchymal stem cells. PLoS One (2009) 1.46
The role of SPARC in extracellular matrix assembly. J Cell Commun Signal (2009) 1.43
Production of osteocalcin by human bone cells in vitro. Effects of 1,25(OH)2D3, 24,25(OH)2D3, parathyroid hormone, and glucocorticoids. Metab Bone Dis Relat Res (1984) 1.42
Loci for regulation of bone mineral density in men and women identified by genome wide linkage scan: the FAMOS study. Hum Mol Genet (2005) 1.42
Targeted disruption of the Wnt regulator Kremen induces limb defects and high bone density. Mol Cell Biol (2008) 1.41
Wnt signaling inside the nucleus. Cancer Sci (2008) 1.40
NFkappaB p50-CCAAT/enhancer-binding protein beta (C/EBPbeta)-mediated transcriptional repression of microRNA let-7i following microbial infection. J Biol Chem (2009) 1.40
Downregulation of Wnt signaling by increased expression of Dickkopf-1 and -2 is a prerequisite for late-stage osteoblast differentiation of KS483 cells. J Bone Miner Res (2005) 1.39
Osteoblasts directly control lineage commitment of mesenchymal progenitor cells through Wnt signaling. J Biol Chem (2007) 1.37
Characterization of the Kremen-binding site on Dkk1 and elucidation of the role of Kremen in Dkk-mediated Wnt antagonism. J Biol Chem (2008) 1.35
Epigenetic Control of MicroRNA Expression and Aging. Curr Genomics (2009) 1.28
Groucho binds two conserved regions of LEF-1 for HDAC-dependent repression. BMC Cancer (2009) 1.26
Wnt signaling and the regulation of bone mass. Curr Osteoporos Rep (2007) 1.24
Small RNAs, big potential: the role of MicroRNAs in stem cell function. Curr Stem Cell Res Ther (2007) 1.16
Wnt signalling pathway: a new target for the treatment of osteoporosis. Expert Opin Ther Targets (2005) 1.13
Translating insights from development into regenerative medicine: the function of Wnts in bone biology. Semin Cell Dev Biol (2008) 1.11
SFRP2 regulates cardiomyogenic differentiation by inhibiting a positive transcriptional autofeedback loop of Wnt3a. Stem Cells (2007) 1.09
Bone morphogenetic protein-2 down-regulates miR-206 expression by blocking its maturation process. Biochem Biophys Res Commun (2009) 1.06
Osteogenic precursor cells of bone marrow in radiation chimeras. Transplantation (1971) 1.01
Wnt signaling acts and is regulated in a human osteoblast differentiation dependent manner. J Cell Biochem (2008) 1.00
Multilineage differentiation and characterization of the human fetal osteoblastic 1.19 cell line: a possible in vitro model of human mesenchymal progenitors. Stem Cells (2007) 0.99
Origin and characterization of multipotential mesenchymal stem cells derived from adult human trabecular bone. Stem Cells Dev (2005) 0.99
Glycogen synthase kinase-3 inhibition by lithium and beryllium suggests the presence of two magnesium binding sites. Biochem Biophys Res Commun (2002) 0.96
The effects of patient age on human osteoblasts' response to Ti-6Al-4V implants in vitro. J Orthop Res (2004) 0.90
Age-dependent Wnt gene expression in bone and during the course of osteoblast differentiation. Age (Dordr) (2008) 0.86
[Cbfa1/Runx2, an essential transcription factor for the regulation of osteoblast differentiation]. Nihon Rinsho (2002) 0.83
Effect of 1,25-dihydroxyvitamin D3 on alkaline phosphatase activity and collagen synthesis in osteoblastic cells, clone MC3T3-E1. Biochem Biophys Res Commun (1984) 0.82
Characterization of human bone cells in culture. Calcif Tissue Int (1985) 0.81
Influence of experimental conditions on osteoblast activity in human primary bone cell cultures. J Bone Miner Res (1990) 0.81
The inflammatory responses to silk films in vitro and in vivo. Biomaterials (2005) 2.79
Fibroblast growth factor-2 and bone morphogenetic protein-2 have a synergistic stimulatory effect on bone formation in cell cultures from elderly mouse and human bone. J Gerontol A Biol Sci Med Sci (2013) 2.12
miR-29 suppression of osteonectin in osteoblasts: regulation during differentiation and by canonical Wnt signaling. J Cell Biochem (2009) 1.83
Notch 1 impairs osteoblastic cell differentiation. Endocrinology (2003) 1.57
Infrared analysis of the mineral and matrix in bones of osteonectin-null mice and their wildtype controls. J Bone Miner Res (2003) 1.39
Mechanisms of glucocorticoid action in bone. Ann N Y Acad Sci (2002) 1.39
T lymphocyte-deficient mice lose trabecular bone mass with ovariectomy. J Bone Miner Res (2006) 1.26
Alendronate treatment of the brtl osteogenesis imperfecta mouse improves femoral geometry and load response before fracture but decreases predicted material properties and has detrimental effects on osteoblasts and bone formation. J Bone Miner Res (2009) 1.21
CCAAT/enhancer binding protein homologous protein (DDIT3) induces osteoblastic cell differentiation. Endocrinology (2003) 1.21
MicroRNA biogenesis and regulation of bone remodeling. Arthritis Res Ther (2011) 1.11
Stat1 controls postnatal bone formation by regulating fibroblast growth factor signaling in osteoblasts. J Biol Chem (2004) 1.10
Porous tantalum stimulates the proliferation and osteogenesis of osteoblasts from elderly female patients. J Orthop Res (2010) 1.08
Matrix-mediated retention of in vitro osteogenic differentiation potential and in vivo bone-forming capacity by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion. J Biomed Mater Res A (2006) 1.07
Interleukin-7 influences osteoclast function in vivo but is not a critical factor in ovariectomy-induced bone loss. J Bone Miner Res (2006) 1.06
Effect of platelet-rich plasma with autogenous bone graft for maxillary sinus augmentation in a rabbit model. J Oral Maxillofac Surg (2005) 1.05
Nocturnin suppresses igf1 expression in bone by targeting the 3' untranslated region of igf1 mRNA. Endocrinology (2010) 1.00
Thrombospondin-2 and SPARC/osteonectin are critical regulators of bone remodeling. J Cell Commun Signal (2009) 0.98
Effects of transforming growth factor-beta 1 (TGF-beta1) on in vitro mineralization of human osteoblasts on implant materials. Biomaterials (2003) 0.97
Cortisol regulates the expression of Notch in osteoblasts. J Cell Biochem (2002) 0.97
Increased Notch 1 expression and attenuated stimulatory G protein coupling to adenylyl cyclase in osteonectin-null osteoblasts. Endocrinology (2007) 0.96
AU-rich elements in the collagenase 3 mRNA mediate stabilization of the transcript by cortisol in osteoblasts. J Biol Chem (2003) 0.95
Accentuated osteoclastic response to parathyroid hormone undermines bone mass acquisition in osteonectin-null mice. Bone (2008) 0.93
miR-29 promotes murine osteoclastogenesis by regulating osteoclast commitment and migration. J Biol Chem (2013) 0.92
New insights on therapeutic touch: a discussion of experimental methodology and design that resulted in significant effects on normal human cells and osteosarcoma. Explore (NY) (2011) 0.89
Fibroblast growth factor-2 stimulates the proliferation of mesenchyme-derived progenitor cells from aging mouse and human bone. J Gerontol A Biol Sci Med Sci (2010) 0.89
Inactivation of SPARC enhances high-fat diet-induced obesity in mice. Connect Tissue Res (2010) 0.88
Therapeutic touch affects DNA synthesis and mineralization of human osteoblasts in culture. J Orthop Res (2008) 0.86
IGF-I 3' untranslated region: strain-specific polymorphisms and motifs regulating IGF-I in osteoblasts. Endocrinology (2012) 0.84
Effects of glucocorticoids on the skeleton. J Pediatr Endocrinol Metab (2002) 0.84
Fibroblast growth factor-2, bone homeostasis and fracture repair. Curr Pharm Des (2013) 0.84
Do cyclooxygenase-2 knockout mice have primary hyperparathyroidism? Endocrinology (2004) 0.83
Bone matrix osteonectin limits prostate cancer cell growth and survival. Matrix Biol (2012) 0.82
A single nucleotide polymorphism in osteonectin 3' untranslated region regulates bone volume and is targeted by miR-433. J Bone Miner Res (2015) 0.81
Biofield research: a roundtable discussion of scientific and methodological issues. J Altern Complement Med (2012) 0.77
Odontoblast-targeted Bcl-2 overexpression impairs dentin formation. J Cell Biochem (2010) 0.77
11beta-hydroxysteroid dehydrogenase, an amplifier of glucocorticoid action in osteoblasts. J Bone Miner Res (2002) 0.76
Fabrication and characterization of hydroxyapatite-coated polystyrene disks for use in osteoprogenitor cell culture. J Biomater Sci Polym Ed (2010) 0.76
Chronic rhinosinusitis osteoblasts differ in cellular properties from normal bone. Int Forum Allergy Rhinol (2014) 0.75
Optimizing BMP-2-induced bone repair with FGF-2. J Am Acad Orthop Surg (2014) 0.75